美索博拉斯特
MESO
13.28
-0.67
-4.80%
美索博拉斯特
US · MESO
#2849 按市值排名
上市于 2015
13.28
-0.67
-4.80%
实时 - 追踪5344个代码 - 心跳于392秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了6家。
- 机构持股总比例下降了3.8个百分点。
机构持股
- 机构持股比例
- 25.49% -3.80pp
- 机构数量
- 109 -6
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Individual/Insider33.13%
Mutual Fund16.81%
Public Company5.55%
Private Company1.27%
Government Pension Fund0.88%
Sovereign Wealth Fund0.85%
Hedge Fund0.10%
Other41.38%
主要股东 截至 2026-08-27
Gregory George
20.95% · 27.20M 股
Silviu Itescu
5.55% · 7.20M 股
State Street Global Advisors
4.98% · 6.47M 股
William Gueck
4.80% · 6.24M 股
JPMorgan Chase & Co.
4.65% · 6.04M 股
M&G Investment Management Limited
2.73% · 3.55M 股
Vanguard Capital Management, LLC
2.49% · 3.23M 股
BlackRock
1.85% · 2.40M 股
Vanguard Investments Australia Limited
1.62% · 2.10M 股
Dimensional Fund Advisors
1.35% · 1.76M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪25份申报 · 1次买入 · 0次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Gregory George | Director | 20.95% |
| Silviu Itescu | Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director | 5.55% |
| Eric Rose | Chief Medical Officer & Executive Director | 0.52% |
| Jane Bell | Independent Non-Executive Director | 0.05% |
| Philip Krause | Non-Executive Director | 0.02% |
| William Burns | Independent Non-Executive Vice Chairman | 0.02% |
| Lynette Cobley | Director | 0.00% |
| Philip Facchina | Independent Non-Executive Director | 0.00% |
| Josaka Investments Pty Ltd. | -- | -- |
| James O’Brien | Chief Financial Officer | -- |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-03-17 | Eric Rose | Chief Medical Officer & Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Philip Facchina | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | William Burns | Independent Non-Executive Vice Chairman | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Silviu Itescu | Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Lynette Cobley | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Josaka Investments Pty Ltd. | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Jane Bell | Independent Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Philip Krause | Non-Executive Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Gregory George | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-15 | Gregory George | Director | Initial Statement of Beneficial | 0 | -- |
| 2025-12-22 | James O’Brien | Chief Financial Officer | Other Derivative Acquisition | +650,000 | $2.90 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
美索博拉斯特 讨论区 0 条评论